Indoco Remedies Ltd.

NSE: INDOCO | BSE: 532612 | ISIN: INE873D01024 | Industry: Pharmaceuticals
| Momentum Trap
273.5500 0.45 (0.16%)
NSE Sep 05, 2025 15:31 PM
Volume: 9,873
 

273.55
0.16%
ICICI Securities Limited
ICICI Securities Ltd | Retail Equity Research Revenues grew 10% YoY to | 281 crore (I-direct estimate: | 307 crore) mainly due to 22% growth in domestic formulations to | 169 crore. Export formulation grew 6% YoY to | 98 crore EBITDA margins fell 302 bps YoY to 14.9% (I-direct estimate: 17.7%) mainly due to an increase in employee cost and other expenditure. EBITDA fell 8% to | 42 crore (I-direct estimate: | 54 crore) Net profit declined 2% YoY to | 22 crore (I-direct estimate: | 30...
Indoco Remedies Ltd. has an average target of 325.00 from 2 brokers.
More from Indoco Remedies Ltd.
Recommended